Assessing Insulin Sensitivity and Postprandial Triglyceridemic Response Phenotypes With a Mixed Macronutrient Tolerance Test

John W Newman, Sridevi Krishnan, Kamil Borkowski, Sean H Adams, Charles B Stephensen, Nancy L Keim, John W Newman, Sridevi Krishnan, Kamil Borkowski, Sean H Adams, Charles B Stephensen, Nancy L Keim

Abstract

The use of meal challenge tests to assess postprandial responses in carbohydrate and fat metabolism is well established in clinical nutrition research. However, challenge meal compositions and protocols remain a variable. Here, we validated a mixed macronutrient tolerance test (MMTT), containing 56-g palm oil, 59-g sucrose, and 26-g egg white protein for the parallel determination of insulin sensitivity and postprandial triglyceridemia in clinically healthy subjects. The MMTT was administered in two study populations. In one, women with overweight/obese BMIs (n = 43) involved in an 8-week dietary intervention were administered oral glucose tolerance tests (OGTTs) and MMTTs within 2 days of each other after 0, 2, and 8 weeks of the dietary intervention. In the other, 340 men and women between 18 and 64 years of age, with BMI from 18-40 kg/m2, completed the MMTT as part of a broad nutritional phenotyping effort. Postprandial blood collected at 0, 0.5, 3, and 6 h was used to measure glucose, insulin, and clinical lipid panels. The MMTT postprandial insulin-dependent glucose disposal was evaluated by using the Matsuda Index algorithm and the 0- and 3 h blood insulin and glucose measures. The resulting MMTT insulin sensitivity index (ISIMMTT) was strongly correlated (r = 0.77, p < 0.001) with the OGTT-dependent 2 h composite Matsuda index (ISIComposite), being related by the following equation: Log (ISIComposite) = [0.8751 x Log(ISIMMTT)] -0.2115. An area under the triglyceride excursion curve >11.15 mg/mL h-1 calculated from the 0, 3, and 6 h blood draws established mild-to-moderate triglyceridemia in agreement with ∼20% greater prevalence of hypertriglyceridemia than fasting indications. We also demonstrated that the product of the 0 to 3 h and 3 to 6 h triglyceride rate of change as a function of the triglyceride incremental area under the curve optimally stratified subjects by postprandial response patterns. Notably, ∼2% of the population showed minimal triglyceride appearance by 6 h, while ∼25% had increasing triglycerides through 6 h. Ultimately, using three blood draws, the MMTT allowed for the simultaneous determination of insulin sensitivity and postprandial triglyceridemia in individuals without clinically diagnosed disease.

Clinical trial registration: [https://ichgcp.net/clinical-trials-registry/NCT02298725" title="See in ClinicalTrials.gov">NCT02298725; NCT02367287].

Keywords: fat tolerance test; insulin patterns; insulin sensitivity; meal challenge test; phenotyping; postprandial triglyceridemia; triglyceridemia.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Newman, Krishnan, Borkowski, Adams, Stephensen and Keim.

Figures

FIGURE 1
FIGURE 1
Study recruitment and data restrictions for the mixed macronutrient tolerance test (MMTT) analysis. (A) The individual Metabolism and Physiological Signatures Study (iMAPS) recruited 52 female (F) individuals with BMIs in the overweight to the obese range. Of these, 44 completed the entire 8-week intervention. A single individual was lost to the triglyceride analysis due to difficulty in blood collection (B) The WHNRC nutritional phenotyping study recruited 393 male (M) and F participants with attempts to balance into 3 age and BMI ranges. Of these, 340 were retained for analyses.
FIGURE 2
FIGURE 2
Glucose and insulin responses of insulin-sensitive and insulin-resistant iMAPS participants to a 75 g glucose oral glucose tolerance test (OGTT) and a 50 g sucrose containing mixed macronutrient meal challenge test (MMTT). The OGTT (A) glucose and (B) insulin responses of participants identified as insulin sensitive (n = 8) or insulin sensitive (n = 35) by the 2 h ISIComposite. The MMTT (C) glucose and (D) insulin responses of the participants identified as insulin sensitive (n = 10) or insulin sensitive (n = 33), the 3 h ISIMMTT. In panels (A–D): • = insulin sensitive; ○ = insulin resistance. (E) iMAPS participant MMTT-dependent postprandial insulin response patterns. (F) Phenotyping participant MMTT-dependent postprandial insulin response patterns. Postprandial response patterns were adapted from previously reported 4 h OGTT-dependent insulin response patterns (–31). Pattern I – normal = peak insulin at 0.5 h, 3 h insulin <20% of 0.5 h insulin; Pattern II – delayed insulin decline = peak insulin at 0.5 h, 3 h insulin <between 20 and 65% of 0.5 h insulin; Pattern III – delayed peak insulin = 3 h insulin >65% of 0.5 h insulin; Pattern IV – high-fasting insulin – 0 h insulin >50-μ units/ml; Pattern V- low insulin = no insulin >15-μ units/ml. iMAPS results are the mean ± standard error of the means of triplicate measurements at 0, 2, and 8 weeks of intervention. Phenotyping results are means ± standard errors of the participants within each postprandial insulin pattern.
FIGURE 3
FIGURE 3
Postprandial triglyceride response in phenotyping cohort individuals characterized with normal triglyceridemia, normal triglyceridemia to mild hypertriglyceridemia, mild-to-moderate hypertriglyceridemia. Cutoffs established for the normal, normal-mild, and mild-moderate postprandial triglyceridemia were 11.15 and 14.47 mg/ml h–1 for the 6 h area under the triglyceride curve calculated from the 0, 3, and 6 h plasma measurements (i.e., 6h AUCTG). Measurements that do not share annotations differ at p < 0.05 by Tukey’s HSD post hoc analysis. The normal group 0 to 3 h slopes differ from other groups (p < 0.0001). The normal-mild group 3 to 6 h slopes differ from other groups (p < 0.0016). Results represent means ± standard deviations.
FIGURE 4
FIGURE 4
The postprandial triglyceride area under the curve x kinetic response groups among 340 clinically healthy free-living individuals. Data shown are the mean ± SD for the concentrations of the participants identified within five equal intensity groups of the population-wide Log [AUCTG + 1] and one of 4 postprandial kinetic behaviors (Groups I–IV). (A) Group I plasma triglycerides appeared quickly and disappeared rapidly (n = 54; 16%); (B) Group II plasma triglycerides appeared moderately and disappeared slowly (n = 231; 68%); (C) Group III plasma triglycerides appeared continuously through 6 h (n = 49, 14%); (D) Group IV plasma triglycerides showed low or delayed postprandial appearance (n = 6, 1.8%). Postprandial responses were assigned using the following rules: Group I – [(ka*ke)/AUCTG] < 0.033 and [ka/AUCTG] >0.021; Group II –0.33 ≤[(ka*ke)/AUCTG] < 0.0056 and [ka/AUCTG] >0.01; Group III – [(ka*ke)/AUCTG] ≥0.0056 and (ka/AUCTG) >0.01; Group IV – (ka/AUCTG) ≤0.01]. Time-dependent changes in triglyceride levels within identified kinetic groups were evaluated using least squares regression mixed models with plasma triglyceride levels as the outcome variables with time, the AUCTG kinetic pattern group and the AUCTG intensity group as fixed effects, with the participant as a random effect, followed by Tukey’s HSD post hoc testing. Time points annotated with different letters within each TG kinetic group are different at p < 0.05.
FIGURE 5
FIGURE 5
Phenotyping cohort postprandial triglyceride kinetic analysis demonstrated significant phenotypic variance. Panels show: (A) the triglyceride rate of change in the 0 to 3 h early phase (kEP) as a function of the incremental area under the triglyceride curve (incAUCTG); (B) the triglyceride rate of change in the 3 to 6 h late phase (kLP) as a function of the incAUCTG; (C) A Johnson-normalized kEP x kLP product as a function of the Johnson-normalized incAUCTG. The quartiles of the Johnson Su [(kEP x kLP)/incAUCTG] defined four kinetic response groups (A-D): Group A – early-phase increase/substantial late-phase decrease (orange; n = 86); Group B – early-phase increase/minimal late-phase decrease (blue; n = 83); Group C – early-phase increase/no late-phase decrease (green; n = 85); Group D – early-phase increase/late-phase increase (purple; n = 84). Note, quartiles do not have the same number of participants due to a small percentage of individuals with identical values. The Johnson Su [(kEP x kLP)/incAUCTG] and kLP/incAUCTG differ between each kinetic group by one-way ANOVA with a Tukey post hoc analysis (p < 0.05). Symbols indicate the estimated postprandial triglyceridemia: • = Normal (6h AUCTG <11.15 mg/ml h–1); ○ = mild-moderate (6h AUCTG >11.15 mg/ml h– 1).
FIGURE 6
FIGURE 6
The postprandial triglyceride incremental area under the curve x kinetic response patterns of 340 clinically healthy free-living individuals. Triglyceride kinetic response types A, B, C, and D are defined by the quartiles of the Johnson Su [(kEP x kLP)/incAUCTG], which describes the product of the 0 to 3 h and 3 to 6 h triglyceride rates of change in relation to the incremental area under the triglyceride curve. The range of the population-wide Log [incAUCTG + 1] was further subdivided into five equal TG concentration intensity groups. (A) Plasma triglyceride kinetic response Group A showed a rapid early period increase and late-period decrease. (B) Plasma triglyceride kinetic response Group B showed modest early-period increase with minimal but significant late-period decrease. (C) Plasma triglyceride kinetic response Group C showed apparent modest early-period increase but insignificant TG change in the late period. (D) Plasma triglyceride kinetic response Group D showed elevating TG levels in both the early and late periods. The occurrence of mild-to-moderate triglyceridemia by the kinetic group was A (n = 38; 44%), B (n = 19; 22%), C (n = 20; 23%) and D (n = 30; 36%). Results are means ± stdev of each intensity group. Time-dependent changes in triglyceride levels within identified kinetic groups were evaluated using least squares regression mixed models with fasting-corrected plasma triglyceride levels as the outcome variables, time, the incAUCTG kinetic pattern group, and the incAUCTG intensity group as fixed effects, and the participant as a random effect, followed by Tukey’s HSD post hoc testing. Time points annotated with different letters within each TG kinetic group are different at p < 0.05.
FIGURE 7
FIGURE 7
The intra-individual variance in (A) early-phase postprandial triglyceride change (kEP) and (B) late-phase postprandial triglyceride change (kLP) from the plasma measured at 0, 2, and 8 weeks of the iMAPS dietary intervention. The 43 participants are ordered by decreasing kEP x kLP and colored by the median kEP x kLP kinetic quartile group (A, B, C, or D) of the three measurements. Considering all participants, and controlling for the participant as a random effect, EP increased (p = 0.012) and kLP tended to decrease (p = 0.06) over the 8-week intervention, but was not affected by diet type, age, or BMI.
FIGURE 8
FIGURE 8
Resting and postprandial energy metabolism shows subtle differences among MMTT triglyceride kinetic response groups. Mixed models of (A) resting and postprandial energy expenditure (EE) and (B) the respiratory exchange ratio (RER) were constructed using lean body mass, BMI, time, and the Johnson (kEP x kLP)/incAUCTG kinetic quartile group as fixed effects and the participant as random effect. Results are adjusted least square means ± standard errors. Results of contrast post-tests of Group A vs. other kinetic groups are shown. Constructing the same models with Johnson (kEP x kLP)/incAUCTG as a continuous variable indicated a negative correlation between this factor and EE (p = 0.0056) but not RER (p = 0.1).

References

    1. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. (2005) 26:19–39.
    1. Enkhmaa B, Ozturk Z, Anuurad E, Berglund L. Postprandial lipoproteins and cardiovascular disease risk in diabetes mellitus. Curr Diab Rep. (2010) 10:61–9. 10.1007/s11892-009-0088-4
    1. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. (2007) 298:309–16. 10.1001/jama.298.3.309
    1. Gutch M, Kumar S, Razi S, Gupta K, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. (2015) 19:160–4.
    1. Quon MJ. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab. (2001) 86:4615–7. 10.1210/jcem.86.10.7952
    1. Mohan V, Amutha A, Ranjani H, Unnikrishnan R, Datta M, Anjana RM, et al. Associations of beta-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians. Diabetes Technol Ther. (2013) 15:315–22. 10.1089/dia.2012.0259
    1. Ishimwe MCS, Wentzel A, Shoup EM, Osei-Tutu NH, Hormenu T, Patterson AC, et al. Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study. BMJ Open Diabetes Res Care. (2021) 9:e002447. 10.1136/bmjdrc-2021-002447
    1. Maki KC, Mckenney JM, Farmer MV, Reeves MS, Dicklin MR. Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose. Nutr J. (2009) 8:22. 10.1186/1475-2891-8-22
    1. Selimoglu H, Duran C, Kiyici S, Guclu M, Ersoy C, Ozkaya G, et al. Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects. Endocrine. (2009) 36:299–304. 10.1007/s12020-009-9213-z
    1. Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED, et al. Additive effect of polymorphisms in the IL-6, LTA, and TNF-{alpha} genes and plasma fatty acid level modulate risk for the metabolic syndrome and its components. J Clin Endocrinol Metab. (2010) 95:1386–94. 10.1210/jc.2009-1081
    1. Pellis L, Van Erk MJ, Van Ommen B, Bakker GC, Hendriks HF, Cnubben NH, et al. Plasma metabolomics and proteomics profiling after a postprandial challenge reveal subtle diet effects on human metabolic status. Metabolomics. (2012) 8:347–59. 10.1007/s11306-011-0320-5
    1. Van Dijk SJ, Mensink M, Esser D, Feskens EJ, Muller M, Afman LA. Responses to high-fat challenges varying in fat type in subjects with different metabolic risk phenotypes: a randomized trial. PLoS One. (2012) 7:e41388. 10.1371/journal.pone.0041388
    1. Van Ommen B, Van Der Greef J, Ordovas JM, Daniel H. Phenotypic flexibility as key factor in the human nutrition and health relationship. Genes Nutr. (2014) 9:423. 10.1007/s12263-014-0423-5
    1. O’Doherty AF, Sathyapalan T, Rigby AS, Ingle L, Carroll S. The repeatability of the abbreviated (4-h) Oral Fat Tolerance Test and influence of prior acute aerobic exercise. Eur J Nutr. (2018) 57:309–18. 10.1007/s00394-016-1320-z
    1. Wopereis S, Wolvers D, Van Erk M, Gribnau M, Kremer B, Van Dorsten FA, et al. Assessment of inflammatory resilience in healthy subjects using dietary lipid and glucose challenges. BMC Med Genomics. (2013) 6:44. 10.1186/1755-8794-6-44
    1. Krishnan S, Adams SH, Allen LH, Laugero KD, Newman JW, Stephensen CB, et al. A randomized controlled-feeding trial based on the dietary guidelines for Americans on cardiometabolic health indexes. Am J Clin Nutr. (2018) 108:266–78. 10.1093/ajcn/nqy113
    1. Baldiviez LM, Keim NL, Laugero KD, Hwang DH, Huang L, Woodhouse LR, et al. Design and implementation of a cross-sectional nutritional phenotyping study in healthy US adults. BMC Nutr. (2017) 3:79. 10.1186/s40795-017-0197-4
    1. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. (1949) 109:1–9. 10.1113/jphysiol.1949.sp004363
    1. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. (2003) 88:1019–23. 10.1210/jc.2002-021127
    1. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care. (2010) 33:e93–93. 10.2337/dc10-0646
    1. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. (1999) 22:1462–70. 10.2337/diacare.22.9.1462
    1. Hucking K, Watanabe RM, Stefanovski D, Bergman RN. OGTT-derived measures of insulin sensitivity are confounded by factors other than insulin sensitivity itself. Obesity (Silver Spring). (2008) 16:1938–45. 10.1038/oby.2008.336
    1. Takahara M, Katakami N, Kaneto H, Noguchi M, Shimomura I. Distribution of the matsuda index in Japanese healthy subjects. J Diabetes Investig. (2013) 4:369–71. 10.1111/jdi.12056
    1. Moshkovits Y, Rott D, Chetrit A, Dankner R. The association between insulin sensitivity indices, ECG findings and mortality: a 40-year cohort study. Cardiovasc Diabetol. (2021) 20:97. 10.1186/s12933-021-01284-9
    1. Chen Z, Caulfield MP, Mcphaul MJ, Reitz RE, Taylor SW, Clarke NJ. Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory. Clin Chem. (2013) 59:1349–56. 10.1373/clinchem.2012.199794
    1. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. (2012) 97:2969–89. 10.1210/jc.2011-3213
    1. Lu HX, Du J, Wen DL, Sun JH, Chen MJ, Zhang AQ, et al. Development and validation of a novel predictive score for sepsis risk among trauma patients. World J Emerg Surg. (2019) 14:11. 10.1186/s13017-019-0231-8
    1. Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Garcia F, De Francisco A, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord. (2013) 13:47. 10.1186/1472-6823-13-47
    1. Kraft JR. Detection of diabetes mellitus in situ (Occult Diabetes). Lab Med. (1975) 6:10–22. 10.1093/labmed/6.2.10
    1. Crofts C, Schofield G, Zinn C, Wheldon M, Kraft J. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: an examination of the Kraft database. Diabetes Res Clin Pract. (2016) 118:50–7. 10.1016/j.diabres.2016.06.007
    1. Dinicolantonio JJ, Bhutani J, Jh OK, Crofts C. Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk. Open Heart. (2017) 4:e000656. 10.1136/openhrt-2017-000656
    1. Barber TM, Kyrou I, Randeva HS, Weickert MO. Mechanisms of insulin resistance at the crossroad of obesity with associated metabolic abnormalities and cognitive dysfunction. Int J Mol Sci. (2021) 22:546. 10.3390/ijms22020546
    1. Meigs JB, D’agostino RB, Sr., Wilson PW, Cupples LA, Nathan DM, Singer DE. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. (1997) 46:1594–600. 10.2337/diacare.46.10.1594
    1. Nichols GA, Horberg M, Koebnick C, Young DR, Waitzfelder B, Sherwood NE, et al. Cardiometabolic Risk Factors Among 1.3 Million Adults With Overweight or Obesity, but Not Diabetes, in 10 Geographically Diverse Regions of the United States, 2012-2013. Prev Chronic Dis. (2017) 14:E22. 10.5888/pcd14.160438
    1. Kim H, Kim K, Shin S. Cardiometabolic risk factor in obese and normal weight individuals in community dwelling men. Int J Environ Res Public Health. (2020) 17:8925. 10.3390/ijerph17238925
    1. Kolovou GD, Mikhailidis DP, Kovar J, Lairon D, Nordestgaard BG, Ooi TC, et al. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol. (2011) 9:258–70. 10.2174/157016111795495549
    1. Nordestgaard BG, Freiberg JJ. Clinical relevance of non-fasting and postprandial hypertriglyceridemia and remnant cholesterol. Curr Vasc Pharmacol. (2011) 9:281–6. 10.2174/157016111795495585
    1. Keirns BH, Sciarrillo CM, Koemel NA, Emerson SR. Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk. J Nutr Sci. (2021) 10:e75. 10.1017/jns.2021.73
    1. Ryan MF, O’grada CM, Morris C, Segurado R, Walsh MC, Gibney ER, et al. Within-person variation in the postprandial lipemic response of healthy adults. Am J Clin Nutr. (2013) 97:261–7. 10.3945/ajcn.112.047936
    1. Tentolouris N, Kanellos PT, Siami E, Athanasopoulou E, Chaviaras N, Kolovou G, et al. Assessment of the validity and reproducibility of a novel standardized test meal for the study of postprandial triacylglycerol concentrations. Lipids. (2017) 52:675–86. 10.1007/s11745-017-4275-9
    1. Stroeve JH, Van Wietmarschen H, Kremer BH, Van Ommen B, Wopereis S. Phenotypic flexibility as a measure of health: the optimal nutritional stress response test. Genes Nutr. (2015) 10:459. 10.1007/s12263-015-0459-1
    1. Wopereis S, Stroeve JHM, Stafleu A, Bakker GCM, Burggraaf J, Van Erk MJ, et al. Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge. Genes Nutr. (2017) 12:21. 10.1186/s12263-017-0570-6
    1. Zhang JQ, Ji LL, Fogt DL, Fretwell VS. Effect of exercise duration on postprandial hypertriglyceridemia in men with metabolic syndrome. J Appl Physiol (1985). (2007) 103:1339–45. 10.1152/japplphysiol.00181.2007
    1. Rijkelijkhuizen JM, Girman CJ, Mari A, Alssema M, Rhodes T, Nijpels G, et al. Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort. Diabetes Res Clin Pract. (2009) 83:280–8. 10.1016/j.diabres.2008.11.017
    1. Maraki M, Aggelopoulou N, Christodoulou N, Katsarou C, Anapliotis P, Kavouras SA, et al. Validity of abbreviated oral fat tolerance tests for assessing postprandial lipemia. Clin Nutr. (2011) 30:852–7. 10.1016/j.clnu.2011.05.003
    1. Lee CJ, Brown T, Magnuson TH, Egan JM, Carlson O, Elahi D. Hormonal response to a mixed-meal challenge after reversal of gastric bypass for hypoglycemia. J Clin Endocrinol Metab. (2013) 98:E1208–12. 10.1210/jc.2013-1151
    1. O’Doherty AF, Sathyapalan T, Rigby AS, Ingle L, Carroll S. The repeatability of the abbreviated (4-h) Oral Fat Tolerance Test and influence of prior acute aerobic exercise. Eur J Nutr. (2016) 57:309–18.
    1. Lambert JE, Parks EJ. Postprandial metabolism of meal triglyceride in humans. Biochim Biophys Acta. (2012) 1821:721–6. 10.1016/j.bbalip.2012.01.006
    1. Morentin Gutierrez P, Yates J, Nilsson C, Birtles S. Evolving data analysis of an oral lipid tolerance test toward the standard for the oral glucose tolerance test: cross species modeling effects of AZD7687 on plasma triacylglycerol. Pharmacol Res Perspect. (2019) 7:e00465. 10.1002/prp2.465
    1. Tushuizen ME, Pouwels PJ, Bontemps S, Rustemeijer C, Matikainen N, Heine RJ, et al. Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome. Atherosclerosis. (2010) 211:308–14. 10.1016/j.atherosclerosis.2010.02.002
    1. Carstensen M, Thomsen C, Hermansen K. Incremental area under response curve more accurately describes the triglyceride response to an oral fat load in both healthy and type 2 diabetic subjects. Metabolism. (2003) 52:1034–7. 10.1016/s0026-0495(03)00155-0
    1. Tiihonen K, Rautonen N, Alhoniemi E, Ahotupa M, Stowell J, Vasankari T. Postprandial triglyceride response in normolipidemic, hyperlipidemic and obese subjects - the influence of polydextrose, a non-digestible carbohydrate. Nutr J. (2015) 14:23. 10.1186/s12937-015-0009-0
    1. Samson CE, Galia AL, Llave KI, Zacarias MB, Mercado-Asis LB. Postprandial peaking and plateauing of triglycerides and VLDL in patients with underlying cardiovascular diseases despite treatment. Int J Endocrinol Metab. (2012) 10:587–93. 10.5812/ijem.4783
    1. Jackson KG, Knapper-Francis JM, Morgan LM, Webb DH, Zampelas A, Williams CM. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men. Clin Sci (Lond). (2003) 105:457–66. 10.1042/CS20030134
    1. Van Oostrom AJ, Alipour A, Sijmonsma TP, Verseyden C, Dallinga-Thie GM, Plokker HW, et al. Comparison of different methods to investigate postprandial lipaemia. Neth J Med. (2009) 67:13–20.
    1. Min KB, Min JY. Android and gynoid fat percentages and serum lipid levels in United States adults. Clin Endocrinol (Oxf). (2015) 82:377–87. 10.1111/cen.12505
    1. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT. Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care. (2013) 36:845–53. 10.2337/dc12-0840
    1. Olefsky J, Farquhar JW, Reaven GM. Sex difference in the kinetics of triglyceride metabolism in normal and hypertriglyceridaemic human subjects. Eur J Clin Invest. (1974) 4:121–7. 10.1111/j.1365-2362.1974.tb00382.x
    1. Wang X, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it’s not just about sex hormones. J Clin Endocrinol Metab. (2011) 96:885–93. 10.1210/jc.2010-2061

Source: PubMed

3
Se inscrever